• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲型血友病合并Ⅰ型血管性血友病:一项家族研究,包括对去氨加压素输注效果的评估。

Combined haemophilia A and type I von Willebrand's disease: a family study including an evaluation of the effects of DDAVP infusion.

作者信息

Casonato A, Pontara E, Boscaro M, Dannhauser D, Sartori M T, Girolami A

机构信息

Institute of Medical Semeiotics, University of Padua, Italy.

出版信息

Haematologia (Budap). 1993;25(1):57-67.

PMID:8339998
Abstract

A family with concurrent haemophilia A and type I von Willebrand's disease (vWd) is described. The propositus was affected by both disorders. The propositus' mother was an obligate carrier of haemophilia A being the daughter of a haemophilic. The father and sister were affected by vWd. The sister was also a possible carrier of haemophilia A. This is the first report of both disorders occurring simultaneously. The infusion of 1-desamino-8-d-arginine vasopressin (DDAVP) induced, in the propositus, a normalization of circulating levels of vWf, with a less pronounced enhancement of factor VIII:C. In the father, the response to DDAVP infusion of factor VIII/vWf complex was normal. In the mother, the time-course of factor VIII:C was characterized, after a peak at 30 min, by a progressive decrease until 2 hours after infusion, in contrast to vWf which appeared further increased at the same times. Therefore, the low factor VII:C/vWf:Ag ratio, already present before infusion, became significantly more pronounced 2 hours after DDAVP. Similar findings were observed in another obligate carrier of the family, in the propositus' sister and in 10 other haemophilia A carriers, belonging to different kindreds. In all patients, even when the basal factor VIII:C/vWf:Ag ratio was normal, two hours after DDAVP it decreased in agreement with the haemophilia A carrier state.

摘要

本文描述了一个同时患有甲型血友病和Ⅰ型血管性血友病(vWd)的家族。先证者同时患有这两种疾病。先证者的母亲是甲型血友病的必然携带者,她是一名血友病患者的女儿。父亲和姐姐患有vWd。姐姐也可能是甲型血友病的携带者。这是两种疾病同时发生的首例报告。对先证者输注1-去氨基-8-D-精氨酸加压素(DDAVP)后,循环中血管性血友病因子(vWf)水平恢复正常,而凝血因子Ⅷ:C的升高则不太明显。在父亲中,DDAVP输注后因子Ⅷ/vWf复合物的反应正常。在母亲中,凝血因子Ⅷ:C的时间进程在输注后30分钟达到峰值,随后逐渐下降,直至输注后2小时,而vWf在同一时间进一步升高。因此,输注前就已存在的低因子Ⅶ:C/vWf:Ag比值在DDAVP输注后2小时变得更加明显。在该家族的另一名必然携带者、先证者的姐姐以及另外10名来自不同家族的甲型血友病携带者中也观察到了类似的结果。在所有患者中,即使基础因子Ⅷ:C/vWf:Ag比值正常,DDAVP输注后2小时该比值也会下降,这与甲型血友病携带者状态相符。

相似文献

1
Combined haemophilia A and type I von Willebrand's disease: a family study including an evaluation of the effects of DDAVP infusion.甲型血友病合并Ⅰ型血管性血友病:一项家族研究,包括对去氨加压素输注效果的评估。
Haematologia (Budap). 1993;25(1):57-67.
2
DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor.去氨加压素对甲型血友病携带者的输注:血浆凝血因子 VIII 和血管性血友病因子的不同表现
Blood Coagul Fibrinolysis. 1996 Jul;7(5):549-53.
3
First report of combined factor VII Padua defect and von Willebrand's disease due to casual association of the two defects.首例因两种缺陷偶然并存导致的联合因子 VII 帕多瓦缺陷与血管性血友病的报告。
Blood Coagul Fibrinolysis. 1993 Feb;4(1):177-81.
4
A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.血管性血友病的一种新变体(帕多瓦I型):在所有大小的多聚体存在下,由双重结构组成的血浆血管性血友病因子寡聚体
Haematologia (Budap). 1994;26(2):97-109.
5
Discrepant increase in factor VIII: C and von Willebrand factor after DDAVP infusion in a patient with variant von Willebrand's disease.1-去氨基-8-D-精氨酸加压素输注后,一名血管性血友病变异型患者的凝血因子VIII:C和血管性血友病因子出现差异增加。
Blood Coagul Fibrinolysis. 1991 Aug;2(4):567-73.
6
Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.1型和2型先天性血管性血友病患者血管性血友病因子参数对去氨加压素的反应:诊断和治疗意义
Semin Thromb Hemost. 2002 Apr;28(2):111-32. doi: 10.1055/s-2002-27814.
7
Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.1型/2E型(2A亚型IIE)血管性血友病、1型维琴察型血管性血友病以及由血管性血友病因子基因的D3、D4、B1 - B3和C1 - C2结构域突变引起的轻型1型血管性血友病的实验室诊断。血管性血友病因子多聚体及血管性血友病因子前肽/抗原比值的作用。
Acta Haematol. 2009;121(2-3):128-38. doi: 10.1159/000214853. Epub 2009 Jun 8.
8
Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.静脉注射去氨加压素和因子VIII-血管性血友病因子浓缩物用于治疗和预防1型、2型和3型血管性血友病患者的出血。
Clin Appl Thromb Hemost. 2007 Jan;13(1):14-34. doi: 10.1177/1076029606296399.
9
Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders.去氨加压素对先天性出血性疾病患儿止血作用的评估。
Haemophilia. 2008 May;14(3):524-30. doi: 10.1111/j.1365-2516.2008.01672.x. Epub 2008 Feb 18.
10
The effect of DDAVP infusion on thrombin generation in platelet-rich plasma of von Willebrand type 1 and in mild haemophilia A patients.去氨加压素输注对1型血管性血友病患者富血小板血浆及轻度甲型血友病患者凝血酶生成的影响。
Thromb Haemost. 2000 Oct;84(4):638-42.

引用本文的文献

1
The Bleeding Assessment Tool and laboratory data in the characterisation of a female with inherited haemophilia A.出血评估工具及实验室数据在遗传性甲型血友病女性患者特征描述中的应用
Blood Transfus. 2018 Jan;16(1):114-117. doi: 10.2450/2016.0132-16. Epub 2016 Nov 15.